肠道杆菌的扫描电镜观察

我们用扫描电镜观察肠道杆菌种(Enterobacteriaceae)中的四种细菌,大肠埃希氏杆菌(Escherichiacoli),普通变形杆菌(Proteus vulgaris),伤寒沙门氏菌(Salmonella typhi)和福氏志贺氏菌(Shigella Flexneri)。未处理的菌落标本,菌落表面都可形成一层厚薄不同的表膜(Surface film)。四种细菌菌落的表膜,形状不一,千姿百态。适当处理后的菌落标本,则可显示菌体的本来面目。四种细菌菌体在菌落表面的分布和排列,也是各不相同,千差万别。本文根据扫描电镜的观察,对四种不同菌落进行了讨论。     

Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli

Post-weaning diarrhea due to enterotoxigenic Escherichia coli (ETEC) is a common disease of piglets and causes great economic loss for the swine industry. Over the past few decades, decreasing effectiveness of conventional antibiotics has caused serious problems because of the growing emergence of multidrug-resistant (MDR) pathogens. Various studies have indicated that antimicrobial peptides (AMPs) have potential to serve as an alternative to antibiotics owing to rapid killing action and highly selective toxicity. Our previous studies have shown that AMP GW-Q4 and its derivatives possess effective antibacterial activities against the Gram-negative bacteria. Hence, in the current study, we evaluated the antibacterial efficacy of GW-Q4 and its derivatives against MDR ETEC and their minimal inhibition concentration (MIC) values were determined to be around 2~32 μg/mL. Among them, AMP Q4-15a-1 with the second lowest MIC (4 μg/mL) and the highest minimal hemolysis concentration (MHC, 256 μg/mL), thus showing the greatest selectivity (MHC/MIC = 64) was selected for further investigations. Moreover, Q4-15a-1 showed dose-dependent bactericidal activity against MDR ETEC in time–kill curve assays. According to the cellular localization and membrane integrity analyses using confocal microscopy, Q4-15a-1 can rapidly interact with the bacterial surface, disrupt the membrane and enter cytosol in less than 30 min. Minimum biofilm eradication concentration (MBEC) of Q4-15a-1 is 4× MIC (16 μg/mL), indicating that Q4-15a-1 is effective against MDR ETEC biofilm. Besides, we established an MDR ETEC infection model with intestinal porcine epithelial cell-1 (IPEC-1). In this infection model, 32 μg/mL Q4-15a-1 can completely inhibit ETEC adhesion onto IPEC-1. Overall, these results suggested that Q4-15a-1 may be a promising antibacterial candidate for treatment of weaned piglets infected by MDR ETEC.     

铁氮共掺杂纳米TiO2的水热法制备及其在可见光下抗菌性能的研究

以硫酸氧钛为前驱体，硝酸铁和盐酸胍作为掺杂的铁源和氮源，采用水热法制备了铁氮共掺杂纳米TiO2粉体。利用XRD、BET对样品进行表征，研究了掺杂后TiO2粉体的晶型、粒径、比表面积等性能。结果表明，所制备的共掺杂TiO2粉体呈黄色，均为锐钛矿相TiO2，经谢尔公式计算其粒径约为10nm，比表面积分布为（135～150）m^2／g。采用紫外．可见光漫反射光谱对样品进行表征，结果表明经过铁氮共掺杂改性后的TiO2具有很强的紫外线的吸收能力，并实现了良好的可见光响应。采用菌落计数法进行了样品抗菌性能的研究，在可见光照射下样品对大肠杆菌表现出良好的杀灭性能。     

人Leptin基因的克隆及其在大肠杆菌中的表达

目的克隆Leptin基因,构建其重组表达菌株,并对表达产物进行免疫学鉴定。方法利用RT-PCR方法从脂肪细胞RNA中扩增出人瘦素前体(pre-Leptin)的cDNA片段和去信号肽序列的Leptin成熟基因片段,并插入pET32a中,转化大肠杆菌BL21(DE3),获得表达重组人瘦素(rh-Leptin)的菌株。结果DNA序列分析显示获得的pre-Leptin和成熟基因片段的序列与预计序列一致,菌株诱导后经SDS-PAGE检测,rh-Leptin表达量达菌体总蛋白的40%以上。Western blot分析显示重组Lep-tin具有免疫学活性。结论已获得高效表达Leptin的重组菌株。     

大肠杆菌肉碱脱水酶基因的克隆、测序及高效表达

［摘 要］目的 克隆并表达大肠杆菌肉碱脱水酶基因。方法 用聚合酶链反应（PCR）从大肠杆菌K12s中扩增大肠杆菌肉碱脱水酶基因caiB，测定其DNA序列，将caiB基因重组到T7启动子控制下的表达载体pET－28a（＋）中，构建表达质粒pETCaiB，转化大肠杆菌BL21（DE3），用1mmol/L异两基硫代-β-D半乳糖苷（IPTG）诱导表达。结果 克隆得到的肉碱脱水酶编码基因 caiB长度为 1221bp，与文献报道值相比,DNA序列有26个不同，氨基酸序列只有一个不同，即302位的丙氨酸变为苏氨酸。重组菌经IPTG诱导，可高效表达，SDS－PAGE分析表达蛋白相对分子质量约43000，表达产物含量占菌体总蛋白45％以上。结论 得到了高效表达肉碱脱水酶的重组菌，为制备L-肉碱创造了条件。     

Influence of ionic liquids on the growth ofEscherichia coli

Ionic liquids are compounds that composed only of ions and are liquid at room temperature. Thus, it is normally named room temperature ionic liquid (RTIL). In this study, the application of RTILs to the extractive fermentation of biomaterials was investigated as a substitute of organic solvents. The relative toxicity of the RTILs on the growth ofE. coli was tested. The inhibition of cell growth in the presence of various ionic liquids was measured using solid and liquid culture, and EC₅₀ of each RTILs was calculated. The number of viable and total cells was measured by the number of colonies and optical density, respectively. Effective concentrations of toxicity (EC₅₀) in these tested systems were similar with conventional solvents, such as acetone, acetonitrile, and ethanol. The viability ofE. coli was affected by the polarity and ionic properties of ionic liquids. The resistance of the microorganisms against ionic liquids was different with the cations and anions composing ionic liquids. No general influence of the anionic compound of the ionic liquids was found on toxicity comparing with distinctive influence of cationic moiety.     

用KOH提取重组大肠杆菌中的PHA

用碱消化法从重组大肠杆菌中提取了PHA. 研究了碱液浓度、温度、消化时间及消化过程液固比等参数对产品PHA质量的影响. 提出了二段消化工艺,提高了PHA的产品纯度,所得PHA产品纯度为98.3%,同时较大幅度地降低了PHA的提取成本.     

耐药大肠杆菌的致病性与免疫原性

目的了解大肠杆菌耐药株的致病性与免疫原性。方法临床分离耐药大肠杆菌,经适宜条件培养后接种小鼠,观察耐药菌株对小鼠的致病性;并选择已知血清型的不同耐药谱和不同耐药水平的菌,分别培养至对数生长期,经甲醛灭活后免疫小鼠,2周后分别用致死剂量的原菌株和同期分离菌株进行攻毒,考察耐药菌株免疫原性。结果24株耐药菌普通肉汤培养物分别感染小鼠,在接种后18h,存活率仅为4%。只有2株菌在1周内仍不能将小鼠全部致死,经小鼠体内传3代后,可在18h内致死小鼠。耐药谱广的菌株感染的小鼠,心肌发生颗粒变性、局灶性出血、坏死;肝脏糖元溶解,脂肪变性;脾脏轻度淤血,淋巴细胞减少;肾脏出血,肾小球肾炎,上皮细胞颗粒变性,水泡变性。而耐药种类少的菌株与对照敏感菌株感染的小鼠主要特征为脾脏出血、淤血,坏死,脾小体消失;肠上皮细胞坏死、脱落、卡他性肠炎。免疫小鼠以免疫用菌株攻毒,均可得较高的保护率,最低为75%,最高为100%。免疫小鼠用非免疫菌株攻毒,小鼠感染后症状出现较缓慢,在18h后出现死亡高峰。耐药种类少的菌株免疫小鼠,对同期分离的非免疫用的致病性大肠杆菌攻击的保护率偏低,而对受试的11种抗生素耐受7种以上的菌株免疫小鼠后,对致病大肠杆菌攻击的保护率显著提高,多数达到75%以上,经统计学分析差异显著。结论耐药大肠杆菌具有较强致病性,且耐药特性与其免疫保护效果相关,多重耐药株对当前流行菌株具有更好的免疫保护作用。     

胸腺素α1的基因合成、表达及活性测定

目的　合成胸腺素α1(Tα1)基因并在原核细胞中表达。方法　用半酶半化学合成并克隆Tα1基因 ,将该基因插入表达质粒pGEX 4T 1并在大肠杆菌进行表达 ,对表达的融合蛋白GST Tα1利用亲和层析法纯化 ,再经Thrombin酶切后 ,获得重组Tα1进行生物学活性检测。结果　经测序证实合成的Tα1序列与设计的一致。构建的重组表达载体pGEX 4T 1 Tα1在大肠杆菌中得到高效表达。E玫瑰花结形成试验证明重组Tα1具有生物学活性。结论　合成的Tα1基因在大肠杆菌中表达出具有生物活性的蛋白。     

幽门螺杆菌过氧化氢酶基因克隆及表达

目的 克隆幽门螺杆菌(Helicobacter pylori,HP)过氧化氢酶(katA)基因并在大肠杆菌中进行表达。方法 采用PCR扩增幽门螺杆菌katA全长基因,将其克隆入pET-11c载体中,经测序证实后,在大肠杆菌中进行表达,产物用Western blot检测其抗原性并进行N末端氨基酸的测序。结果 幽门螺杆菌katA基因全长1 518bp,编码氨基酸505个。在BL21(DE3)中的表达量约占细菌总蛋白的24.9％,表达产物经SDS-PAGE显示其相对分子质量与软件预测结果 58 000相符,N末端5个氨基酸测序结果与Hp中天然的katA完全一致,经Western blot检测可被 Hp全菌抗血清识别。结论 katA能在大肠杆菌中进行高效表达,具有良好的免疫反应性,可望为研究 Hp的致病机理、实验诊断及亚单位疫苗等提供充足的katA原材料。